Your browser doesn't support javascript.
loading
NCI 8628: A randomized phase 2 study of ziv-aflibercept and high-dose interleukin 2 or high-dose interleukin 2 alone for inoperable stage III or IV melanoma.
Tarhini, Ahmad A; Frankel, Paul; Ruel, Christopher; Ernstoff, Marc S; Kuzel, Timothy M; Logan, Theodore F; Khushalani, Nikhil I; Tawbi, Hussein A; Margolin, Kim A; Awasthi, Sanjay; Butterfield, Lisa H; McDermott, David; Chen, Alice; Lara, Primo N; Kirkwood, John M.
Afiliação
  • Tarhini AA; University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Frankel P; Department of Hematology and Oncology, Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center, Cleveland, Ohio.
  • Ruel C; City of Hope National Medical Center, Duarte, California.
  • Ernstoff MS; City of Hope National Medical Center, Duarte, California.
  • Kuzel TM; Roswell Park Comprehensive Cancer Center, Buffalo, New York.
  • Logan TF; Rush University Medical Center, Chicago, Illinois.
  • Khushalani NI; Indiana University Melvin and Bren Simon Cancer Center, Indianapolis, Indiana.
  • Tawbi HA; Moffitt Cancer Center, Tampa, Florida.
  • Margolin KA; The University of Texas MD Anderson Cancer Center, Houston, Texas.
  • Awasthi S; City of Hope National Medical Center, Duarte, California.
  • Butterfield LH; City of Hope National Medical Center, Duarte, California.
  • McDermott D; University of Pittsburgh Medical Center Hillman Cancer Center, University of Pittsburgh, Pittsburgh, Pennsylvania.
  • Chen A; Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Lara PN; Department of Surgery, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
  • Kirkwood JM; Department of Immunology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Cancer ; 124(22): 4332-4341, 2018 11 15.
Article em En | MEDLINE | ID: mdl-30303516
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Interleucina-2 / Receptores de Fatores de Crescimento do Endotélio Vascular / Melanoma Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Recombinantes de Fusão / Interleucina-2 / Receptores de Fatores de Crescimento do Endotélio Vascular / Melanoma Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Ano de publicação: 2018 Tipo de documento: Article